Target intelligence / Profile preview

Gonadotropin-releasing hormone 1 (GNRH1)

Target
GNRH1
Molecular classification
Peptide hormone, Hypothalamic hormone
01

Overview

Gonadotropin-releasing hormone 1 (GNRH1) is a decapeptide neurohormone synthesized in the hypothalamus and released in a pulsatile manner into the hypophyseal portal system. It stimulates the anterior pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn regulate gonadal steroidogenesis and gametogenesis. GNRH1 is the central regulator of the hypothalamic-pituitary-gonadal axis in vertebrates. Clinically, GNRH1 and its synthetic analogs serve as key therapeutic agents for reproductive disorders, hormone-dependent cancers, and as tools for pituitary function testing. Overexpression or aberrant signaling of GnRH or its receptor is implicated in various hormone-dependent malignancies, establishing it as an important therapeutic target.

Other names
Progonadoliberin-1Gonadoliberin-1GnRH-associated peptide 1GNRHGRHLHRHGnRH-ILH-RH ILNRHProgonadoliberin IGonadoliberin IGonadorelinGonadotropin-releasing hormone ILuliberin ILuteinizing hormone-releasing hormone Iprolactin release-inhibiting factor
02

Mechanism of action

Agonists stimulate pituitary GnRH receptors to cause FSH and LH release; antagonists block these receptors to suppress gonadotropin secretion; both approaches modulate sex steroid production for clinical use in hormone-sensitive cancers and reproductive disorders

03

Biological functions

Reproductive hormone releaseRegulation of reproductive axisSignal transductionNeuroendocrine signaling
04

Disease associations

Cancer (breast, prostate, ovarian, endometrial, renal, pancreatic, lung, melanoma, glioblastoma)Hypogonadotropic hypogonadismInfertilityHormone-dependent diseases
05

Safety considerations

Hypogonadismosteoporosishot flashesrisk of cardiovascular/metabolic disturbances (with prolonged sex steroid suppression)tumor flare with agonists (short term)injection site reactionspituitary apoplexy in rare cases
06

Interacting drugs

Leuprorelin

8 more in the full profile.

07

Biomarkers

GnRH1 expression (immunohistochemistry in certain cancers)LH and FSH response in GnRH stimulation test (diagnostic)

Beyond the preview

Go deeper on Gonadotropin-releasing hormone 1 (GNRH1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gonadotropin-releasing hormone 1 (GNRH1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call